http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2016003211-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1a28bf222c19af8535f8661fbc09441
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-41
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-12
filingDate 2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_334a49bd2afae5fd14a44492e935a490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87380513e439d03dc7bb85519a860110
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae4ad7f12d8578020abbff23a8e43ddb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf1add9dfd7ced743b29cb2b975de4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c3e1dd15e8c28e84ebd72466ad5dfc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4c9e1e98e37b2ebfdbe46ec2242e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8ddeacdd42db01829bb64f2ec768b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb527f102e4f31320bff3e0a3bd15a70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4112ea629e590146101f02f533d3d970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2263f54c84389228c3bdeed876df4281
publicationDate 2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2016003211-A
titleOfInvention PROCESSES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND INTERMEDIATE COMPOUNDS FOR USE IN THEM.
abstract The present invention provides a compound of the formula N wherein: X is CH2, oxygen or sulfur; R1, R2 and R3 are the same or different and mean hydrogens, halogens, alkyl, alkyloxy, hydroxy, nitro, alkylcarbonylamino, alkylamino or dialkylamino, wherein N is in the individual form of (R) - or (S) -enantiomer or a mixture of (R) - and (S) -enantiomers. The present invention also provides a compound of formula MA. The present invention also provides processes for preparing the above compounds, and processes that imply their use. The compounds are particularly useful as intermediates in the synthesis of peripherally selective dopamine-β-hydroxylase inhibitors.
priorityDate 2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 33.